Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA
On February 19, 2024, the Journal of American Medical Association•Neurology published online the key findings of a phase III clinical study investigating Sanbexin® sublingual tablets for the treatment of acute ischemic stroke.
Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA Read More »
